Laropiprant mixture with niacin
2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid;pyridine-3-carboxylic acid
Molecular Identity
Laropiprant mixture with niacin
2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid;pyridine-3-carboxylic acid
PubChem CID: 11948701
2D Structure
Properties
C27H24ClFN2O6S
Molecular Formula
559.00
Molecular Weight
g/mol
558.1028
Exact Mass
Da
135
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
8
H-Bond Acceptors
834
Complexity
SMILES
Canonical SMILES
SMILES: CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F.C1=CC(=CN=C1)C(=O)OIsomeric SMILES
SMILES: CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CC[C@@H]3CC(=O)O)CC4=CC=C(C=C4)Cl)F.C1=CC(=CN=C1)C(=O)OSynonyms(18)
TredaptiveLaropiprant / niacinPelzontTrevaclynLaropiprant-niacin mixt.Niacin-laropiprant mixt.MK0524AMK 0524A1046050-73-0Laropiprant / nicotinic acidDTXSID80146612Cyclopent(b)indole-3-acetic acid, 4-((4-chlorophenyl)methyl)-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3R)-, mixt. with 3-pyridinecarboxylic acidRefChem:798525DTXCID2069103Laropiprant+niacin
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Laropiprant mixture with niacin
Loading drug network...